9,10-dimethyl-1,2-benzanthracene has been researched along with Ductal Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gear, R; Heffelfinger, SC; LaDow, K; Lu, F; Schneider, J; Warshawsky, D; Yan, M | 1 |
1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Ductal Carcinoma
Article | Year |
---|---|
Expression of angiogenic factors is upregulated in DMBA-induced rat mammary pathologies.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenic Proteins; Angiopoietin-1; Animals; Carcinogens; Carcinoma in Situ; Carcinoma, Ductal; Female; Fibroblast Growth Factor 2; Gene Expression Profiling; Gene Expression Regulation; Hyperplasia; Insulin Receptor Substrate Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Osteonectin; Phosphoproteins; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Thrombospondin 1; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A | 2004 |